Cellular Biomedicine Group

Gems gemstones diamonds precious treasure
Biotech

Identifying 'gems': J&J gives insider look at dealmaking spree

Janssen’s global head of business development tells Fierce that the company sees “tremendous potential for patients in employing precision medicine.”
James Waldron May 15, 2023 5:00am
Janssen

J&J refuels CAR-T ambitions with $245M Cellular Biomedicine deal

May 2, 2023 9:13am